Paper Details

  1. Home
  2. Paper Details

A systematic review of treatment strategies for erythrodermic psoriasis.

Author: LeeErica B, LiaoWilson, PithadiaDeeti J, ReynoldsKelly A, WuJashin J

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Erythrodermic psoriasis (EP), a severe form of psoriasis, can be life-threatening. This review found that various biologic and systemic medications, such as TNF inhibitors, interleukin-17 inhibitors, ustekinumab, cyclosporine, etretinate, and methotrexate, have shown promise in improving EP symptoms. Treatment decisions should consider the severity of the condition and the patient's overall health. While some evidence exists, more high-quality research is needed to determine the best treatments for EP.
Paper Details　
Original Abstract of the Article :
<b>Background:</b> Erythrodermic psoriasis (EP) is a severe, rare form of psoriasis that can be life threatening. Treatment of EP is usually based on anecdotal evidence or past clinical experience, which is in part due to the rarity and often emergent nature of this psoriasis subtype.<b>Methods:</b...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1080/09546634.2019.1689228

データ提供：米国国立医学図書館（NLM）

Unveiling the Mysteries of Erythrodermic Psoriasis

Erythrodermic psoriasis (EP), a rare and severe form of psoriasis, is a formidable foe, often leaving patients feeling like their skin is a burning desert. This study delves into the treatment strategies for EP, a complex and challenging area of dermatology. The authors meticulously reviewed a vast collection of studies, uncovering the effectiveness of various therapeutic approaches. This research provides a much-needed roadmap for navigating the treatment of this formidable skin condition.

Biological Therapies Emerge as a Promising Oasis

The study highlights the remarkable efficacy of biological therapies in treating EP. Drugs targeting tumor necrosis factor (TNF) and interleukin-17 (IL-17) have shown promising results in rapidly improving skin condition and providing much-needed relief to patients. These findings underscore the potential of targeted therapies in revolutionizing the treatment of severe psoriasis.

Navigating the Treatment Landscape with Caution

The study emphasizes the need for a tailored approach to EP treatment, taking into account the severity of the condition and individual patient factors. The authors remind us that EP is a complex and challenging disease, and the choice of treatment should be carefully considered in consultation with a qualified dermatologist.

Dr.Camel's Conclusion

This study offers a valuable guide for navigating the challenging waters of EP treatment. The emergence of biological therapies represents a significant step forward in providing effective and targeted treatment options for this debilitating condition. The study underscores the importance of individualized care and the need for continued research to further understand and address the complexities of EP.

Date :
  1. Date Completed 2020-12-29
  2. Date Revised 2020-12-29
Further Info :

Pubmed ID

31682547

DOI: Digital Object Identifier

10.1080/09546634.2019.1689228

Related Literature

Article Analysis
・Effective treatment of psoriasis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.